iSpecimen Inc. (ISPC)
NASDAQ: ISPC · IEX Real-Time Price · USD
0.280
-0.013 (-4.30%)
Jul 22, 2024, 10:14 AM EDT - Market open
iSpecimen Employees
iSpecimen had 53 employees as of December 31, 2023. The number of employees decreased by 22 or -29.33% compared to the previous year.
Employees
53
Change (1Y)
-22
Growth (1Y)
-29.33%
Revenue / Employee
$174,868
Profits / Employee
-$218,298
Market Cap
3.67M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 53 | -22 | -29.33% |
Dec 31, 2022 | 75 | 16 | 27.12% |
Dec 31, 2021 | 59 | 18 | 43.90% |
Dec 31, 2020 | 41 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
China Pharma Holdings | 231 |
Regional Health Properties | 114 |
OpGen | 100 |
Sintx Technologies | 43 |
Genprex | 26 |
Onconetix | 12 |
Bio-Path Holdings | 10 |
ISPC News
- 2 months ago - iSpecimen Reports First Quarter 2024 Results - GlobeNewsWire
- 3 months ago - iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024 - GlobeNewsWire
- 4 months ago - iSpecimen Reports Full Year 2023 Results - GlobeNewsWire
- 4 months ago - iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call - GlobeNewsWire
- 4 months ago - iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024 - GlobeNewsWire
- 6 months ago - iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research - GlobeNewsWire
- 6 months ago - iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024 - GlobeNewsWire
- 8 months ago - iSpecimen Strengthens Global Oncology Biospecimen Offering - GlobeNewsWire